Position in CRMD
as of Mar 31, 2026
· filed May 18, 2026
Position Value
$983,429
-$535,087 QoQ
Shares Held
144,835
+10.9% QoQ
Ownership
0.185%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
24 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in CRMD Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026BANK OF AMERICA CORP /DE/ holds $8,548,750,242 across 347 Biotechnology names. CRMD ranks #211 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
2,878,183 | $1,285,223,834 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
1,189,584 | $919,120,177 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
966,912 | $319,922,169 | |
| 4 | ARGX |
Argenx SE
|
400,117 | $292,185,437 | |
| 5 | INSM |
INSMED Inc
|
1,502,281 | $245,652,986 | |
| 6 | CYTK |
Cytokinetics Inc
|
3,125,436 | $205,997,485 | |
| 7 | JAZZ |
Jazz Pharmaceuticals plc
|
1,014,800 | $191,847,936 | |
| 8 | HALO |
Halozyme Therapeutics, Inc.
|
2,913,109 | $188,274,232 |
All Filings in CRMD
Export CSV
24 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $983,429 | 144,835 | Shares | Defined | 2026-05-18 | |
| 2025-12-31 | $1,518,516 | 130,569 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $3,311,152 | 284,708 | Shares | Defined | 2026-02-03 | |
| 2025-06-30 | $2,621,732 | 212,803 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $239,062 | 38,809 | Shares | Defined | 2025-05-15 | |
| 2024-12-31 | $486,931 | 60,115 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $476,647 | 58,991 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $164,439 | 37,977 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $119,384 | 28,157 | Shares | Defined | 2024-05-15 | |
| 2023-12-31 | $235,676 | 62,680 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $119,583 | 32,320 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $97,530 | 24,567 | Shares | Defined | 2023-08-14 | |
| 2022-12-31 | $65,869 | 15,609 | Shares | Defined | 2023-02-10 | |
| 2022-09-30 | $20,876 | 7,377 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $29,249 | 7,276 | Shares | Defined | 2022-08-12 | |
| 2022-03-31 | $148,545 | 27,107 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $254,034 | 55,832 | Shares | Defined | 2022-02-08 | |
| 2021-09-30 | $178,962 | 38,487 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $236,819 | 34,522 | Shares | Defined | 2021-09-13 | |
| 2021-03-31 | $670,016 | 67,069 | Shares | Defined | 2021-05-14 | |
| 2020-12-31 | $232,833 | 31,337 | Shares | Defined | 2021-02-10 | |
| 2020-09-30 | $160,638 | 26,640 | Shares | Defined | 2020-11-13 | |
| 2020-06-30 | $175,863 | 27,915 | Shares | Defined | 2020-08-14 | |
| 2020-03-31 | $57,441 | 16,001 | Shares | Defined | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||